Notably, they included DMRs close to many genes previously implicated in prostate cancer (e.g., NEAT1, MTOR, RHCG, KCNC2, WT1, HOXC12, KMT2B, Fig. 5b). This evidence concerns the gene MTOR and Familial prostate cancer.